MOREPENLAB

Morepen Laboratories LimitedNSELive
₹56.6-1.63 (-2.80%)

Market Open · NSE · INR

Open

₹58.4

High

₹58.48

Low

₹56.05

Prev Close

₹58.23

52-Week Range77% from low
₹33.68
₹63.47

Market Cap

₹3190.73 Cr

Small Cap

P/E (TTM)

33.66

EPS

₹1.73

Div Yield

0.34%

P/B Ratio

2.49

ROE

7.6%

Key Metrics

Forward P/E-
Book Value₹22.76
Debt/Equity0.16×
Revenue Growth4.0%
Profit Margin3.25%
Operating Margin6.96%
Volume46.75 L
Avg Volume (20d)1.42 Cr
Delivery %36.96%
Trades14,958

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally. The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, an...

morepen.com1,814 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 0.20/share
29 Aug 20250.20
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.